Principle, Not Profit: Inside Marcelo V. Personal

Why It Matters

The judgment forces insurers to apply the SABS injury definitions rather than their own impairment assessments, expanding claimants’ access to benefits and prompting industry‑wide policy reviews.

Key Takeaways

• Court ruled brain contusion cannot be classified as minor injury
• Decision resets policy limitation clock, extending claim period by five years
• Insurers must rely on injury definition, not perceived impairment, under SABS
• MIG’s $3,500 CAD cap (~$2,600 USD) unsuitable for brain trauma
• Case creates precedent for reclassification challenges across Ontario personal injury sector

Pulse Analysis

Ontario’s personal injury insurance system is governed by the Statutory Accident Benefits Schedule (SABS), which separates injuries into minor and catastrophic categories. The Minor Injury Guideline (MIG) was designed for musculoskeletal wounds, offering a $3,500 CAD (about $2,600 USD) benefit cap and a 12‑week restoration model. Insurers often lean on this framework to limit payouts, classifying even serious conditions as "minor" when they believe the claimant’s functional impairment is low. This practice has drawn criticism for ignoring the medical reality of injuries such as intracranial contusions, which demand long‑term neuropsychological care.

In Marcelo v. Personal, the Ontario Divisional Court rejected the insurer’s narrow reading of the MIG, emphasizing that the SABS explicitly allows a brain contusion to trigger a catastrophic designation. By declaring the insurer’s reliance on perceived impairment an error of law, the court reset the statutory limitation clock, granting the claimant a fresh five‑year window to pursue benefits. The decision not only restores the client’s access to appropriate treatment but also signals a potential financial exposure for insurers who have been classifying complex injuries under the MIG’s modest cap.

The precedent is likely to ripple across the province’s personal injury landscape. Legal teams representing claimants now have a clearer pathway to challenge inappropriate MIG classifications, especially for neurological or internal injuries that fall outside the guideline’s musculoskeletal focus. Insurers may need to revise underwriting policies, invest in more thorough medical assessments, and reconsider benefit structures to avoid costly appeals. For the broader market, the ruling reinforces consumer‑protective principles embedded in the SABS, encouraging a shift toward more equitable treatment of serious injuries and prompting regulators to examine whether the MIG framework requires modernization.